Consortium of Multiple Sclerosis Centers Annual Meeting (CMSC)
The Consortium of Multiple Sclerosis Centers Annual Meeting is the leading research and educational conference for multiple sclerosis healthcare professionals of all disciplines in North America.
Cladribine Reduces MRI Lesions Across Subgroups in ORACLE-MS Study
May 28th 2019The subgroups were defined by baseline characteristics that are known to be potential modifiers of risk to conversion to clinically-definite multiple sclerosis, including age, gender, first classification of demyelinating event, presence of T1 Gd+ lesions, and number of active T2 lesions.
